Terazosin Capsule
Product Images NDC 71610-786

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71610-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5 mg (71610 0786 60)

Terazosin Hydrochloride 5 mg oral capsules, bottle containing 90 capsules. The label shows the product name, strength, quantity, and NDC 71610-0786-60. Manufactured by Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD, and repackaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN 38506.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure diagram of Terazosin Hydrochloride, showing its molecular arrangement including aromatic rings, amine groups, and other chemical moieties along with the hydrochloride component.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

This image contains two line graphs comparing placebo and Terazosin in a clinical study. The left graph shows mean change in total symptom score from baseline over 3 months, with Terazosin demonstrating a greater decrease than placebo. The right graph depicts mean increase in peak flow rate (mL/sec) from baseline over the same period, with Terazosin showing a larger increase compared to placebo.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph showing mean change from baseline over a 30-month period, with data points plotted at various months including 0,1,2,3,6,9,12,15,18,21,24,27, and 30. The y-axis represents mean change from baseline ranging from 0 to -6, and the x-axis represents time in months. Several points are marked with asterisks indicating statistical significance.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph showing mean change from baseline over time in months (0 to 30). The y-axis measures change in units per second, with values from 0.0 to 4.5. Data points with error bars and markers indicate trends and variability. Asterisks denote statistically significant changes at various months.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.